The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy
Open accessAbstract
During bone modeling, remodeling, and bone fracture repair, mesenchymal stem cells (MSCs) differentiate into chondrocyte or osteoblast to comply bone formation and regeneration. As multipotent stem cells, MSCs were used to treat bone diseases during the past several decades. However, most of these implications just focused on promoting MSC differentiation. Furthermore, cell migration is also a key issue for bone formation and bone diseases treatment. Abnormal MSC migration could cause different kinds of bone diseases, including osteoporosis. Additionally, for bone disease treatment, the migration of endogenous or exogenous MSCs to bone injury sites is required. Recently, researchers have paid more and more attention to two critical points. One is how to apply MSC migration to bone disease therapy. The other is how to enhance MSC migration to improve the therapeutic efficacy of bone diseases. Some considerable outcomes showed that enhancing MSC migration might be a novel trick for reversing bone loss and other bone diseases, such as osteoporosis, fracture, and osteoarthritis (OA). Although plenty of challenges need to be conquered, application of endogenous and exogenous MSC migration and developing different strategies to improve therapeutic efficacy through enhancing MSC migration to target tissue might be the trend in the future for bone disease treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A. M., & Silberstein, L. E. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0319 · Cited by 722
Role of mesenchymal stem cells in bone regeneration and fracture repair: a review
Wang, X., Wang, Y., Gou, W., Lu, Q., Peng, J., & Lu, S. (2013) · International Orthopaedics · doi:10.1007/s00264-013-2059-2 · Cited by 357
Self-citationThe influence of osteoporosis in femoral fracture healing time
Nikolaou, V. S., Efstathopoulos, N., Kontakis, G., Kanakaris, N. K., & Giannoudis, P. V. (2009) · Injury · doi:10.1016/j.injury.2008.10.035 · Cited by 185
Li, A., Xia, X., Yeh, J., Kua, H., Liu, H., Mishina, Y., Hao, A., & Li, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113785 · Cited by 100
Cited by
Mesenchymal Stem Cell Migration and Tissue Repair
Fu, X., Liu, G., Halim, A., Ju, Y., Luo, Q., & Song, G. (2019) · Cells · doi:10.3390/cells8080784 · Cited by 1,044
Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
Xiao, S., Zhao, T., Wang, J., Wang, C., Du, J., Ying, L., Lin, J., Zhang, C., Hu, W., Wang, L., et al. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09893-4 · Cited by 363
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
Noh, J.-Y., Yang, Y., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207623 · Cited by 287
Mesenchymal stem cells: Amazing remedies for bone and cartilage defects
Kangari, P., Talaei-Khozani, T., Razeghian-Jahromi, I., & Razmkhah, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02001-1 · Cited by 286
Metadata
- Authors
- Su, P., Tian, Y., Yang, C., Ma, X., Wang, X., Pei, J., & Qian, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-08-09
- Volume
- 19
- Issue
- 8
- Pages
- 2343
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2887439803
- Cited by
- 269
- References
- 4
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy. https://app.cochat.ai/papers/10.3390/ijms19082343
- The paper
- Su, P., Tian, Y., Yang, C., Ma, X., Wang, X., Pei, J., & Qian, A. (2018). Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19082343
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.